• Patient Education

Patient Education: Idecabtagene Vicleucel (CART Cell Therapy) - Immunotherapy

Updated: Mar 27

Patient Education: Idecabtagene Vicleucel


ABECMA (idecabtagene vicleucel) is a B-cell maturation antigen (BCMA)-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.

IDE-CEL (Abecma) CART Cell Therapy for Multiple Myeloma

Idecabtagene Vicleucel ( Abecma)

NIH National cancer institute - cancer.gov site info

This page contains brief information and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s): Abecma

FDA Approved: Yes

Learn more: https://www.cancer.gov/about-cancer/treatment/drugs/idecabtagenevicleucel

 

MedlinePlus Information

A lay language summary of important information about this drug that may include the following:

warnings about this drug,

what this drug is used for and how it is used,

what you should tell your doctor before using this drug,

what you should know about this drug before using it,

other drugs that may interact with this drug, and

possible side effects.

Learn more: https://medlineplus.gov/druginfo/meds/a621024.html

 

Information on Abecma website

https://www.abecma.com/receiving-abecma/

 

INTERNATIONAL MYELOMA FOUNDATION:


Understanding ABECMA® (idecabtagene vicleucel)

Understanding ABECMA® (idecabtagene vicleucel) | International Myeloma Foundation

Download Booklet here


IMF Understanding Series

https://www.myeloma.org/cancer-information-series


IMF Resource Library

https://www.myeloma.org

https://www.myeloma.org/publications-videos

https://www.youtube.com/c/IMFMyeloma/videos


Current FDA-Approved Medications for Multiple Myeloma Treatment

https://www.myeloma.org/multiple-myeloma-drugs

 

HEALTH TREE UNIVERSITY MYELOMA:

All about Abecma (Idecabtagene Vicleucel)

Watch Video on YouTube


HealthTree University for Multiple Myeloma Lectures

https://healthtree.org/myeloma/university/courses

https://healthtree.org/


Health Tree University Myeloma Videos

https://www.youtube.com/c/HealthTreeUniversity/videos

 

MULTIPLE MYELOMA RESERACH FOUNDATION:


Standard Treatments - (BCMA)-directed personalized immunotherapy Abecma

https://themmrf.org/multiple-myeloma/treatment-options/standard-treatments/abecma/

https://themmrf.org/multiple-myeloma/treatment-options/standard-treatments/


MMRF Education Programs

https://themmrf.org/resources/education-programs/

https://themmrf.org/


MMRF Videos

https://www.youtube.com/user/TheMMRF/videos

 

References ABECMA- idecabtagene vicleucel:


FDA Label Prescribing Information (Revised 03/2021)

Prescribing Information | ABECMA


Medication Guide


Drug Label Information at DAILYMED - NIH-National Library of Medicine

DailyMed - ABECMA- idecabtagene vicleucel suspension


Other Resources

Resources & Support

 


- Multiple Myeloma Patient Education & Information on ongoing Multiple Myeloma Clinical Trials -


Posts Archive